Immunexpress announces that FirstHealth of the Carolinas will be adopting SeptiCyte® RAPID in its sepsis care program

Our portfolio company, Immunexpress, a molecular diagnostic company focused on improving outcomes for patients suspected of sepsis, has announced the adoption of SeptiCyte® RAPID by FirstHealth of the Carolinas, a non-profit health system licensed for four hospitals in Pinehurst, Troy, Rockingham and Raeford, North Carolina. SeptiCyte RAPID will be available at FirstHealth as a tool in differentiating sepsis-positive cases from patients with infection negative systemic inflammation.

SeptiCyte RAPID fills a largely unmet need for the rapid diagnosis  of patients with escalating signs and symptoms of sepsis  and the test provides clinicians with actionable results in approximately one hour from a simple blood draw. We look forward to  contributing to improved patient outcomes for individuals suspected of sepsis, and to the rollout of SeptiCyte RAPID in healthcare systems in the United States and beyond.

said Rollie Carlson, Ph.D., Chief Executive Officer of Immunexpress.

Access to their full press release here